{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:09:03Z","timestamp":1780675743661,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["292611, 279163, 295504, 310507, 313267, 326238"],"award-info":[{"award-number":["292611, 279163, 295504, 310507, 313267, 326238"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-019-0122-4","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T17:02:28Z","timestamp":1575910948000},"page":"568-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":172,"title":["Prediction of drug combination effects with a minimal set of experiments"],"prefix":"10.1038","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-482X","authenticated-orcid":false,"given":"Aleksandr","family":"Ianevski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1154-8501","authenticated-orcid":false,"given":"Prson","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kononov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Saarela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krister","family":"Wennerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-9769","authenticated-orcid":false,"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"122_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrd.2016.3","volume":"15","author":"RM Webster","year":"2016","unstructured":"Webster, R. M. Combination therapies in oncology. Nat. Rev. Drug Discov. 15, 81\u201382 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"122_CR2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","volume":"27","author":"J Leh\u00e1r","year":"2009","unstructured":"Leh\u00e1r, J. et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 27, 659\u2013666 (2009).","journal-title":"Nat. Biotechnol."},{"key":"122_CR3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O\u2019Neil","year":"2016","unstructured":"O\u2019Neil, J. et al. An unbiased oncology compound screen to identify novel combination strategies. Mol. Cancer Ther. 15, 1155\u20131162 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"122_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1535-7163.MCT-16-0235","volume":"16","author":"B Radic-Sarikas","year":"2017","unstructured":"Radic-Sarikas, B. et al. Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities. Mol. Cancer Ther. 16, 88\u2013101 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"122_CR5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nrd3792","volume":"11","author":"G Pelaia","year":"2012","unstructured":"Pelaia, G., Vatrella, A. & Maselli, R. The potential of biologics for the treatment of asthma. Nat. Rev. Drug Discov. 11, 958\u2013972 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"122_CR6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nm0716-694","volume":"22","author":"S Chakradhar","year":"2016","unstructured":"Chakradhar, S. All in one: researchers create combination drugs for diabetes and obesity. Nat. Med. 22, 694\u2013696 (2016).","journal-title":"Nat. Med."},{"key":"122_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","volume":"31","author":"RJ Worthington","year":"2013","unstructured":"Worthington, R. J. & Melander, C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 31, 177\u2013184 (2013).","journal-title":"Trends Biotechnol."},{"key":"122_CR8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.15252\/msb.20156777","volume":"12","author":"S Chandrasekaran","year":"2016","unstructured":"Chandrasekaran, S. et al. Chemogenomics and orthology-based design of antibiotic combination therapies. Mol. Syst. Biol. 12, 872 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"122_CR9","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","volume":"100","author":"AA Borisy","year":"2003","unstructured":"Borisy, A. A. et al. Systematic discovery of multicomponent therapeutics. Proc. Natl Acad. Sci. USA 100, 7977\u20137982 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"122_CR10","volume":"5","author":"BT Mott","year":"2015","unstructured":"Mott, B. T. et al. High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations. Sci. Rep. 5, 13891 (2015).","journal-title":"Sci. Rep."},{"key":"122_CR11","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","volume":"111","author":"LA Mathews Griner","year":"2014","unstructured":"Mathews Griner, L. A. et al. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc. Natl Acad. Sci. USA 111, 2349\u20132354 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"122_CR12","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.chembiol.2014.07.015","volume":"21","author":"WP Janzen","year":"2014","unstructured":"Janzen, W. P. Screening technologies for small molecule discovery: the state of the art. Chem. Biol. 21, 1162\u20131170 (2014).","journal-title":"Chem. Biol."},{"key":"122_CR13","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","volume":"78","author":"L He","year":"2018","unstructured":"He, L. et al. Patient-customized drug combination prediction and testing for T-cell prolymphocytic leukemia patients. Cancer Res. 78, 2407\u20132418 (2018).","journal-title":"Cancer Res."},{"key":"122_CR14","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","volume":"13","author":"SL Holbeck","year":"2017","unstructured":"Holbeck, S. L. et al. The national cancer institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity. Cancer Res. 13, 3564\u20133576 (2017).","journal-title":"Cancer Res."},{"key":"122_CR15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/138920110792927757","volume":"11","author":"A Roy","year":"2010","unstructured":"Roy, A. et al. Open access high throughput drug discovery in the public domain: a Mount Everest in the making. Curr. Pharm. Biotechnol. 11, 764\u2013778 (2010).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"122_CR16","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1073\/pnas.1703094114","volume":"114","author":"SE Kurtz","year":"2017","unstructured":"Kurtz, S. E. et al. Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. Proc. Natl Acad. Sci. USA 114, 7554\u20137563 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"122_CR17","volume":"5","author":"D Yu","year":"2015","unstructured":"Yu, D. et al. Identification of synergistic, clinically achievable, combination therapies for osteosarcoma. Sci. Rep. 5, 16991 (2015).","journal-title":"Sci. Rep."},{"key":"122_CR18","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1158\/0008-5472.CAN-15-3425","volume":"76","author":"T Horn","year":"2016","unstructured":"Horn, T. et al. High-order drug combinations are required to effectively kill colorectal cancer cells. Cancer Res. 76, 6950\u20136963 (2016).","journal-title":"Cancer Res."},{"key":"122_CR19","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/gutjnl-2017-315144","volume":"67","author":"A Chou","year":"2018","unstructured":"Chou, A. et al. Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Gut 67, 2142\u20132155 (2018).","journal-title":"Gut"},{"key":"122_CR20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"Ting-Chao Chou","year":"2006","unstructured":"Chou, Ting-Chao Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621\u2013681 (2006).","journal-title":"Pharmacol. Rev."},{"key":"122_CR21","volume":"5","author":"W Sun","year":"2016","unstructured":"Sun, W. et al. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerg. Microbes Infect. 5, e116 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"122_CR22","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2009-10-248054","volume":"116","author":"M Shehata","year":"2010","unstructured":"Shehata, M. et al. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K\/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia. Blood 116, 2513\u20132521 (2010).","journal-title":"Blood"},{"key":"122_CR23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nbt.2391","volume":"30","author":"X Tan","year":"2012","unstructured":"Tan, X. et al. Systematic identification of synergistic drug pairs targeting HIV. Nat. Biotechnol. 30, 1125\u20131130 (2012).","journal-title":"Nat. Biotechnol."},{"key":"122_CR24","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics 32, 2866\u20132868 (2016).","journal-title":"Bioinformatics"},{"key":"122_CR25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski, A., He, L., Aittokallio, T. & Tang, J. SynergyFinder: a web application for analyzing drug combination dose\u2013response matrix data. Bioinformatics 33, 2413\u20132415 (2017).","journal-title":"Bioinformatics"},{"key":"122_CR26","first-page":"286","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe, S. The problem of synergism and antagonism of combined drugs. Arzneimiettelforschung 3, 286\u2013290 (1953).","journal-title":"Arzneimiettelforschung"},{"key":"122_CR27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"CI Bliss","year":"1939","unstructured":"Bliss, C. I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585\u2013615 (1939).","journal-title":"Ann. Appl. Biol."},{"key":"122_CR28","first-page":"93","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum, M. C. What is synergy? Pharmacol. Rev. 41, 93\u2013141 (1989).","journal-title":"Pharmacol. Rev."},{"key":"122_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav, B. et al. Searching for drug synergy in complex dose-response landscapes using an interaction potency model. Comput. Struct. Biotechnol. J. 13, 504\u2013505 (2015).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"122_CR30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.15252\/msb.20156098","volume":"11","author":"G Chevereau","year":"2015","unstructured":"Chevereau, G. & Bollenbach, T. Systematic discovery of drug interaction mechanisms. Mol. Syst. Biol. 11, 807 (2015).","journal-title":"Mol. Syst. Biol."},{"key":"122_CR31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res"},{"key":"122_CR32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","volume":"30","author":"B Al-Lazikani","year":"2012","unstructured":"Al-Lazikani, B. et al. Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol. 30, 679\u2013692 (2012).","journal-title":"Nat. Biotechnol."},{"key":"122_CR33","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1073\/pnas.1606301113","volume":"113","author":"A Zimmer","year":"2016","unstructured":"Zimmer, A. et al. Prediction of multidimensional drug dose responses based on measurements of drug pairs. Proc. Natl Acad. Sci. USA 113, 10442\u201310447 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"122_CR34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1473-3099(16)30125-6","volume":"16","author":"AC Eziefula","year":"2016","unstructured":"Eziefula, A. C. Artesunate-mefloquine: a malaria treatment for African children? Lancet Infect. Dis. 16, 1086\u20131087 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"122_CR35","doi-asserted-by":"crossref","first-page":"S672","DOI":"10.1093\/infdis\/jiy304","volume":"218","author":"J Dyall","year":"2018","unstructured":"Dyall, J. et al. Identification of combinations of approved drugs with synergistic activity against Ebola virus in cell cultures. J. Infect. Dis. 218, S672\u2013S678 (2018).","journal-title":"J. Infect. Dis."},{"key":"122_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coisb.2017.05.005","volume":"4","author":"ZB Weinstein","year":"2015","unstructured":"Weinstein, Z. B. et al. Prediction of synergistic drug combinations. Curr. Opin. Syst. Biol. 4, 24\u201328 (2015).","journal-title":"Curr. Opin. Syst. Biol."},{"key":"122_CR37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.chembiol.2015.06.021","volume":"22","author":"A Szwajda","year":"2015","unstructured":"Szwajda, A. et al. Systematic mapping of kinase addiction combinations in breast cancer cells by integrating drug sensitivity and selectivity profiles. Chem. Biol. 22, 1144\u20131155 (2015).","journal-title":"Chem. Biol."},{"key":"122_CR38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrd.2018.161","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. Microfluidics platform lowers barrier to drug combination screening. Nat. Rev. Drug Discov. 17, 691\u2013692 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"122_CR39","volume":"15","author":"P Gautam","year":"2016","unstructured":"Gautam, P. et al. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells. Mol. Cancer 15, 34 (2016).","journal-title":"Mol. Cancer"},{"key":"122_CR40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vascn.2014.08.006","volume":"71","author":"SR Gadagkar","year":"2015","unstructured":"Gadagkar, S. R. & Call, G. B. Computational tools for fitting the Hill equation to dose\u2013response curves. J. Pharmacol. Toxicol. Methods 71, 68\u201376 (2015).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"122_CR41","first-page":"4","volume":"40","author":"AV Hill","year":"1910","unstructured":"Hill, A. V. The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J. Physiol. 40, 4\u20137 (1910).","journal-title":"J. Physiol."},{"key":"122_CR42","doi-asserted-by":"crossref","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2015","unstructured":"Ritz, C., Baty, F., Streibig, J. C. & Gerhard, D. Dose\u2013response analysis using R. PLoS One 10, e0146021 (2015).","journal-title":"PLoS One"},{"key":"122_CR43","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1109\/TKDE.2012.51","volume":"25","author":"YX Wang","year":"2013","unstructured":"Wang, Y. X. et al. Non-negative matrix factorization: a comprehensive review. IEEE Trans. Knowl. Data Eng. 25, 1336\u20131353 (2013).","journal-title":"IEEE Trans. Knowl. Data Eng."},{"key":"122_CR44","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1214\/aoms\/1177698699","volume":"38","author":"JH Venter","year":"1967","unstructured":"Venter, J. H. On estimation of the mode. Ann. Math. Stat. 38, 1446\u20131455 (1967).","journal-title":"Ann. Math. Stat."},{"key":"122_CR45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fphar.2015.00181","volume":"6","author":"J Tang","year":"2015","unstructured":"Tang, J., Wennerberg, K. & Aittokallio, T. What is synergy? The Saariselk\u00e4 agreement revisited. Front. Pharmacol. 6, 181 (2015).","journal-title":"Front. Pharmacol."},{"key":"122_CR46","doi-asserted-by":"crossref","unstructured":"Bischl, B. et al. mlrMBO: a modular framework for model-based optimization of expensive black-box functions. Preprint at https:\/\/arxiv.org\/abs\/1703.03373 (2017).","DOI":"10.32614\/CRAN.package.mlrMBO"},{"key":"122_CR47","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. Xgboost: a scalable tree boosting system. In Proc. 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 (ACM, 2016).","DOI":"10.1145\/2939672.2939785"}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-019-0122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-019-0122-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-019-0122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:39:10Z","timestamp":1722159550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-019-0122-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["122"],"URL":"https:\/\/doi.org\/10.1038\/s42256-019-0122-4","relation":{},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}